Developer of a wearable device intended to prevent the progression of glaucoma and irreversible blindness. The company's technology utilizes a microfluidic-based smart contact lens and a smartphone app powered by AI (artificial intelligence) to monitor intraocular pressure (IOP), clinical trials have demonstrated a strong correlation with office-based standard-of-care devices, positioning the company as the first to offer an accurate and convenient method for monitoring the risk and progression of glaucoma, enabling patients to get an efficient and convenient way of monitoring IOP at home.
Bone Health Technologies, Inc. is focused on creating innovative medical devices to combat low bone mass conditions such as osteopenia and osteoporosis. The company's flagship product, OsteoBoost, is a wearable device designed for the lower back that utilizes whole-body vibration technology to deliver gentle mechanical stimulation. This stimulation mimics the effects of weight-bearing exercise, promoting bone health by activating stem cells to strengthen bone density. Founded in 2018 and headquartered in San Francisco, California, Bone Health Technologies aims to provide a safe and effective non-drug intervention for individuals at risk of bone mass deterioration.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.